April 16, 2024
White Paper
Injecting agile production methodologies into clinical trials
Why labeling within the supply chain holds the key
In recent years, the clinical trial sector has gone through unparalleled change. Overnight, the industry had to adjust its way of working as Covid-19 wreaked havoc across the world, and the wider clinical trial supply chain had to adjust to fit a new paradigm.
Many changes brought in for the short term have become a permanent part of the clinical trial landscape. The sector rose to meet the unprecedented challenge and along the way realized that adaptive design, decentralization, and direct-to-patient supply models were also patient centric.
Read this report to see how the industry has shifted its approach to how clinical trial supplies are managed and as a result made the industry more patient centric.
